K
Korea Pharma Co Ltd
KOSDAQ:032300
Korea Pharma Co Ltd
KOSDAQ:032300
Price:
10 930
KRW
-2.32%
Market Closed
Market Cap:
₩119.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Korea Pharma Co Ltd
KOSDAQ:032300
|
KR |
|
F&F Holdings Co Ltd
KRX:007700
|
KR |
|
F
|
Future Care Trading Co
SAU:9544
|
SA |
|
American Woodmark Corp
NASDAQ:AMWD
|
US |
|
ZoomInfo Technologies Inc
NASDAQ:GTM
|
US |
|
S
|
Sejin Heavy Industries Co Ltd
KRX:075580
|
KR |
|
G
|
Gaon Group Ltd
TASE:GAGR
|
IL |
|
KAR Auction Services Inc
NYSE:KAR
|
US |
|
UiPath Inc
NYSE:PATH
|
US |
|
S
|
Sparebank 1 SMN
OSE:MING
|
NO |
Multiples-Based Value
The Multiples-Based Value of one Korea Pharma Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 10 930 KRW, Korea Pharma Co Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Korea Pharma Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Korea Pharma Co Ltd Competitors
Korea Pharma Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
K
|
Korea Pharma Co Ltd
KOSDAQ:032300
|
119.2B KRW | 1.4 | -45.1 | 45 | -115.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
902.5B USD | 13.8 | 43.7 | 29.5 | 31.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581.1B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.9B GBP | 5.4 | 30.9 | 17.1 | 24 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.6B USD | 4.7 | 16.6 | 10.3 | 12.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
234.4B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.6 | 7.8 | 9.2 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.8B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.7B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
